Prescribing information can be found under each product's logo

Cardiology

BEKEMV Logo

Cardiology

Blincyto

Bekemv

Haematology
Blincyto Logo

Cardiology

Blincyto

Blincyto

Haematology
Kyprolis Logo

Cardiology

Kyprolis

Kyprolis

Haematology
Lumykras Logo

Cardiology

Xgeva

Lumykras

Oncology
Mimpara Logo

Cardiology

Mimpara

Mimpara

Nephrology
NPLATE Logo

Cardiology

Nplate

Nplate

Haematology
Otezla Logo

Cardiology

Otezla

Otezla

Inflammation
Parsabiv Logo

Cardiology

Parsabiv

Parsabiv

Nephrology
Prolia Logo

Cardiology

Prolia

Prolia

Bone
Repatha Logo

Cardiology

Repatha

Repatha

Cardiology
Vectibix logo

Cardiology

Vectibix

Vectibix

Oncology
Explore products

Haematology

Explore products

Inflammation

Explore products
GBR-NP-1124-80005 | February 2025
▼ This medicinal product is subject to additional monitoring.
  • Adverse Event Reporting Information
    Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Amgen Limited on +44 (0) 1223 436441.